Behrad Derakhshan

Biography

 Dr. Behrad Derakhshan joined Therachon as Vice President, Head of Business Development in April 2017. Dr. Derakhshan brings 10 years of experience in the rare/ultra-rare disease space, most recently as a Director at Alexion Pharmaceuticals responsible for Business Development and Strategic Evaluation. In this role, he reviewed and evaluated numerous opportunities for potential in-licensing or acquisition. Prior to this role, Dr. Derakhshan served as the Director of New Products, leading Global Commercial Insights and Analytics, also at Alexion, where he provided commercial support for both early stage development and late stage life cycle programs for Alexion’s internal portfolio as well as external Business Development opportunities. Prior to Alexion, Dr. Derakhshan spent several years in life science consulting, first as a Senior Consultant at Easton Associates and then as an Associate Director at Navigant Consulting, Inc. Dr. Derakhshan provided consulting services to numerous Top 20 pharmaceutical, medical device and biotechnology companies, including business development/opportunity searches, corporate and commercial strategies, payer/reimbursement strategies and strategic product development. Dr. Derakhshan conducted his Posdoctoral training at the Yale University School of Medicine and earned his Ph.D. in Pharmacology and Biochemistry from a joint program between Weill Cornell Medical College in New York and the University of Surrey, UK. While at Cornell, he was the recipient of an “International Young Investigator Award” for research performed during his graduate degree. He received a First-Class Honors BSc. with distinction in Biochemistry from the University of Surrey.

Research Interest

 Business Development and Strategic Evaluation.